Reviewing prognostic factors in breast cancer management.

JAAPA : official journal of the American Academy of Physician Assistants

Volumn 20, Issue 5, 2007, Pages 42-46

  Glissmeyer, Margie ^a  

^a Surgical Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; MONOCLONAL ANTIBODY; TAMOXIFEN; TRASTUZUMAB;

BREAST TUMOR; CANCER STAGING; FEMALE; HUMAN; PATHOLOGY; PROGNOSIS; REVIEW;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; AROMATASE INHIBITORS; BREAST NEOPLASMS; FEMALE; HUMANS; NEOPLASM STAGING; PROGNOSIS; TAMOXIFEN;

EID: 34548620950     PISSN: 15471896     EISSN: None     Source Type: Journal    
DOI: 10.1097/01720610-200705000-00009     Document Type: Review

References (29)